Survival benefit stratification of partial nephrectomy versus non‐surgical treatment in elderly patients with T1a renal cell carcinoma
Cancer Medicine · 2023-04 · 12 (7) · 7974-7981
DOI: 10.1002/cam4.5580 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Medicine, online erschienen am 11.01.2023. Verfasst von Yaxiong Tang und 5 weiteren Autor:innen. Beteiligte Einrichtung: West China School of Medicine, West China Hospital, Sichuan University, Chengdu, China. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Kidney Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Renal cell carcinoma (RCC) of stage T1a has been proven to be of low‐grade malignancy and mostly affects elderly individuals with relatively limited life expectancy. However, research on the survival benefit of surgery relative to non‐surgical treatment (NST) is limited. The aim of the study was to investigate the survival difference between partial nephrectomy (PN) and NST and to establish a benefit stratification model for elderly patients (≥70 years) diagnosed with T1a RCC. Patients and Methods Patients diagnosed with non‐metastatic T1a RCC who received PN or NST were identified from the SEER database during 2004–2015. Before survival analysis, propensity score matching (PSM) was performed. Overall survival (OS) was estimated by the Kaplan–Meier method, and subgroup analyses were used to identify favorable factors of PN. Independent factors of survival were recognized by multivariate Cox regression analysis.
Results
Patients diagnosed with non‐metastatic T1a RCC who received PN or NST were identified from the SEER database during 2004–2015. Before survival analysis, propensity score matching (PSM) was performed. Overall survival (OS) was estimated by the Kaplan–Meier method, and subgroup analyses were used to identify favorable factors of PN. Independent factors of survival were recognized by multivariate Cox regression analysis.
Conclusions
Our findings suggest that the survival benefit of PN could be stratified based on the clinical characteristics in patients with stage T1a RCC aged 70 years or older, which may help physicians and patients optimize clinical decisions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- West China School of Medicine, West China Hospital, Sichuan University, Chengdu, China.
ORCID-Profile: Yaxiong Tang, Xu Hu, Xiang Li
Zitieren
APA
Tang, Y., Wu, K., Hu, X., Liu, Y., Yang, W., & Li, X. (2023). Survival benefit stratification of partial nephrectomy versus non‐surgical treatment in elderly patients with T1a renal cell carcinoma. Cancer Medicine, 12(7), 7974-7981. https://doi.org/10.1002/cam4.5580
Vancouver
Tang Y, Wu K, Hu X, Liu Y, Yang W, Li X. Survival benefit stratification of partial nephrectomy versus non‐surgical treatment in elderly patients with T1a renal cell carcinoma. Cancer Medicine. 2023;12(7):7974-7981. doi:10.1002/cam4.5580
BibTeX
@article{Tang2023,
author = {Tang, Yaxiong and Wu, Kan and Hu, Xu and Liu, Yang and Yang, Weixiao and Li, Xiang},
title = {Survival benefit stratification of partial nephrectomy versus non‐surgical treatment in elderly patients with T1a renal cell carcinoma},
journal = {Cancer Medicine},
year = {2023},
volume = {12},
number = {7},
pages = {7974--7981},
doi = {10.1002/cam4.5580}
}
EUVIMED